WallStreetZenWallStreetZen

NASDAQ: NBRV
Nabriva Therapeutics PLC Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their NBRV stock forecasts and price targets.

Forecast return on equity

Is NBRV forecast to generate an efficient return?
Company
N/A
Industry
0.08%
Market
72.92%

Forecast return on assets

Is NBRV forecast to generate an efficient return on assets?
Company
N/A
Industry
0.1%

NBRV revenue growth forecast

How is NBRV forecast to perform vs Biotechnology companies and vs the US market?
Company
57.13%
Industry
39.75%
Market
8.34%
NBRV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NBRV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NBRV vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NBRV$1.55N/AN/A
NRXP$0.70$2.00+185.71%Buy
MEIP$7.34$33.00+349.59%Hold
SURF$0.81$4.50+459.01%Buy
BIOR$4.26$65.00+1,425.82%Buy

Nabriva Therapeutics Stock Forecast FAQ

What is NBRV's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: NBRV) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Nabriva Therapeutics stock.

What is NBRV's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: NBRV) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.1%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.